Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.
about
STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference.
P2860
Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Signal transducer and activato ...... mes in acute myeloid leukemia.
@ast
Signal transducer and activato ...... mes in acute myeloid leukemia.
@en
type
label
Signal transducer and activato ...... mes in acute myeloid leukemia.
@ast
Signal transducer and activato ...... mes in acute myeloid leukemia.
@en
prefLabel
Signal transducer and activato ...... mes in acute myeloid leukemia.
@ast
Signal transducer and activato ...... mes in acute myeloid leukemia.
@en
P2093
P2860
P1476
Signal transducer and activato ...... mes in acute myeloid leukemia.
@en
P2093
P2860
P304
P356
10.1111/J.1751-553X.2012.01406.X
P577
2012-02-29T00:00:00Z